Infectious complications of neoplastic disease.
D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use; D002177:Candidiasis / Q000209:etiology; D003453:Cryptococcosis / Q000209:etiology; D003587:Cytomegalovirus; D004756:Enterobacteriaceae Infections / Q000209:etiology; D004927:Escherichia coli Infections / Q000209:etiology; D006566:Herpesviridae Infections / Q000209:etiology; D006801:Humans; D017053:Infection Control; D007239:Infections / Q000209:etiology*; D007710:Klebsiella Infections / Q000209:etiology; D007938:Leukemia / Q000276:immunology; D008223:Lymphoma / Q000276:immunology; D008228:Lymphoma, Non-Hodgkin / Q000276:immunology; D009181:Mycoses / Q000209:etiology; D009369:Neoplasms / Q000150:complications* / Q000188:drug therapy / Q000276:immunology; D009617:Nocardia Infections / Q000209:etiology; D010272:Parasitic Diseases / Q000209:etiology; D011512:Proteus Infections / Q000209:etiology; D011528:Protozoan Infections / Q000209:etiology; D011552:Pseudomonas Infections / Q000209:etiology; D018805:Sepsis / Q000188:drug therapy / Q000209:etiology / Q000401:mortality; D014123:Toxoplasmosis / Q000209:etiology; D014777:Virus Diseases / Q000209:etiology
D000900:Anti-Bacterial Agents